The Exchange

Existing home sales in April dropping to the lowest point in nearly 10 years as the market got a one-two punch from inventories and prices. So did we hit a bottom in April? And how quickly can the housing market recover? We’ll take a closer look. Plus, the world is racing to develop Covid-19 vaccines at record pace, and at a time when there’s still a lot we don’ t know about the virus. We look at...

With growth stocks are outperforming value names by the widest margin in decades, two portfolio managers duke it out over which is the better bang for your buck. And, from mortgages to mansions—we get reads on the hottest trends in housing. Plus, the CEO of Sony Pictures entertainment joins to discuss Apple TV spending $70m for its new Tom Hanks’ picture and the future of the movie industry as sta...

After Secretary Steve Mnuchin and Fed Chair Jerome Powell gave remote testimony in front of the Senate Banking Committee, we discuss what the next phase of relief out of Washington could look like. And as the retailers report earnings this week, we take a look at why the good ol’ honey-do list could be one of the new trends in the sector. Plus, as banks underperform, the CEO of KBW, which advised...

Markets rallying on promising vaccine news and reassuring words from Federal Reserve Chairman Jay Powell. We’ll talk about what it means for your investments. Plus, investors -big and small-are flocking into the biotech sector in large numbers. We’ll look at the names they’re flowing into and whether you should follow suit. And, if Michael Jordan were a stock, analysts would have a buy rating on t...

Stocks continue to sell off amid increasing China tensions and some weak economic data. One of our guests says there are five things that could cause a another selloff from here. He tells us what they are. Plus, there’s so much we don’t know yet about Covid-19, including what role genetics may be playing in how severely someone gets infected. The CEO of 23andMe joins us with what her company is do...

Eurasia Group’s Ian Bremmer says we’re in the first Depression of our lifetimes and massive relief and subsidies are needed to get us through it. He joins us live with how much pain he sees ahead. Plus, we check back in with one luxury mall owner and operator since he started reopening some of his properties. He tells us how much foot traffic he’s seeing and which brands are doing better than othe...

Stocks selling off as Fed Chair Jay Powell delivers downbeat commentary earlier in the day, adding him to the list of heavyweights, including Warren Buffett and Sam Zell, to warn about the economy. So, should investors be ready for a long winter as we head into summer? We discuss.   And, companies shifted supply chains from China to other parts of the world like India and Vietnam due to the US tra...

A slew of policymakers have come out against the idea of negative rates in the past couple of days but the President likes the idea. We take a closer look at whether negative rates would do more harm than good to the U.S. Plus, the Fed is boldly going where it’s never gone before….the ETF market, specifically corporate bond ETFs. We’ll look at why this could help brighten economic prospects not ju...

Disney reopening its Shanghai Disneyland, making it the first park to reopen during the COVID-19 pandemic—we go live to Shanghai for the details and hear from Disney CEO Bob Chapek on Disney’s path forward to reopening. Plus, the Department of Justice’s assistant Attorney General for National Security joins to discuss the “holy grail” of biomedical research and why China is launching cyberattacks...

20.5 million jobs were lost in the month of April, sending unemployment to 14.7%. Labor Secretary Eugene Scalia joins to discuss the economic impact and whether the worst is behind us.  Plus, during record unemployment, a check on the top industries hiring and the positions that are most in-demand. And, with the NFL announcing its full-season schedule yesterday, we’ll get an inside look at the tim...

Stocks rallying on positive drug news, earnings, and optimism that the economy will improve as states start to reopen. We’ll look at how investors should position themselves as the markets and the economy show signs of life. Plus, a battle is brewing in the education world as to when colleges should open. We’ll speak with the President of the Arizona University who says they’re absolutely planning...

Companies across all sectors are pulling guidance as Covid-19 continues to take its toll on the economy. So how do you invest in a market with no clear outlook? We’ll ask the experts. Plus, a new study by the Federal Reserve shows loans haven’t been going to the hardest-hit areas. We’ll tell you why. And, as auto sales have been hit hard, we’ll speak to the CEO of one company that’s found a way fo...

A CNBC rapid survey showing that economists are feeling positively about third quarter growth, so what should investors do? One top strategist tells us why it’s a bond picker’s market. And WeWork founder Adam Neumann is suing SoftBank for reneging on a multi-billion dollar lifeline. The details on how a relationship went sour and the battle between the personalities behind the two companies. Plus,...

One of our guests correctly called the March bottom and the rebound in energy stocks. Now he says this market rally may be over. He joins us to make his case. Plus, as states begin to reopen, some workers are facing a difficult choice between their health and their livelihood. We have the details. And, Columbus, Ohio has been hit particularly hard financially by the pandemic. The city’s mayor join...

Stocks selling off after a historic month of April. Do investors simply have a hangover or is there real fear that the “new normal” as parts of America reopen is going to be really slow and take a really long time? We’ll take a closer look. Plus, text the store, wait in your car. That’s the new normal at one Detroit mall reopening with curbside pickup today. We’ll talk to the owner of that mall ab...

The Fed is expanding its Main Street lending program to include more businesses and types of loans. But are the Treasury and the Fed taking enough risk to help the economy, and are we seeing that they may not be on the same page? We’ll take a closer look. Plus, as Apple goes, so goes the market. It sounds like an exaggeration but we’ll show you why it might not be. And, we’ll talk to a CEO whose c...

With the Dow climbing 500 points today, the market rally has started to broaden out beyond the FANG stocks… can investors trust this positive momentum? Two strategists weigh in. And with just minutes before the Fed’s interest rate decision, we take a look at why the problems with the Small Business Administration’s PPP lending system could vindicate the Fed for taking its time executing its stimul...

Consumer confidence tanked in April, posting it’s second biggest drop ever. The CEO of The Conference Board tells us what steps need to be taken to revive the economy—and why things could be looking up. R5 Capital’s Scott Mushkin is the only analyst on the Street with a ‘sell’ rating on Amazon…what’s got him bearish about the tech giant. And Northwestern University was given $8.5m in federal aid f...

The S&P is now just 15 percent beneath its all-time high and 30 percent from the lows a month ago despite a pandemic that’s cost 26 million jobs. So is the stock market being too optimistic? We take a closer look at the disconnect between Wall Street and the real economy. Plus, after the disease come the debt. The U.S. is heading for a nearly 4 Trillion dollar deficit this year. How can things get...

Many investors are writing off this earnings season due to the coronavirus but Mohamed El-Erian of Allianz says it’s very important. Who’s right? We debate. Plus, antibody tests are considered key to reopening economies but they are raising alarms. We speak to one expert who says it’s the wild, wild west out there. And, when workers finally return to work, the offices they return to, will likely l...

Stat News reporting that the WHO posted the results of a drug trial in China that revealed Gilead’s remdesivir, an antiviral it had hoped could treat COVID-19, was ineffective. The news sent shares sinking…we talk to the reporter behind the story. And oil clawing its way back after its historic collapse earlier this week, the CEO of a tanker company joins with why that drop is a boon for his compa...

Stocks are rallying for the first time in three days thanks to a reversal higher in oil, earnings, and the Senate passing another massive relief package. But is it enough to keep these markets afloat? We debate. Plus, many companies will have to dramatically change the way they do business when economies reopen. One of our next guests advises companies on how to do just that after a crisis. She te...

The oil selloff continues and one of our guests says the worst it yet to come with -$100 per barrel a real possibility next month. We look at what that would do to an already battered energy industry. Plus, the crude collapse weighing on stocks today but it’s not all bad news. We look at some of the opportunities in the markets. And, they are some of the most critical workers needed right now but...

The May oil contract collapses, sending U.S. crude prices on track for their worst day ever. We explore what it means for the broader energy market, and the millions of workers who depend on the sector for their livelihoods. Plus, many retailers were already struggling BEFORE the COVID-19 crisis. But with even more bankruptcies on the horizon, what might the retail landscape look like after the lo...

Stocks are rallying today on hopes that Gilead’s Coronavirus treatment could be working. We have the details and whether investors can trust this rally. Plus, President Trump wants states to step up their testing but access to tests is still uneven. We have the latest from Washington and where things stand on the testing front across the country. And, more and more people are turning to technology...